Formidable Asset Management LLC trimmed its stake in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARC...
In this episode presented by Eclipsebio, BioSpace's head of insights Lori Ellis discusses mRNA and s...
Wall Street Zen lowered shares of Arcturus Therapeutics from a "hold" rating to a "sell" rating in a...
5 analysts have expressed a variety of opinions on Arcturus Therapeutics (NASDAQ:ARCT) over the past...